Skip to main content

Dr. Derek R. Hanson, M.D.

Pediatric Hematology & Oncology (Pediatric Hematology & Oncology Physician)

At a glance

In the NPI registry since
2008

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Pediatric Hematology & Oncology Physician primary
    MA license 258393 · NY license 260875

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Pediatric Hematology & Oncology per capita by county →

Payments from drug and device companies

In 2025, 2 companies reported 32 payments worth $53,380 in total to this clinician.

By company
Alexion Pharmaceuticals, Inc.$48,748
Day One Biopharmaceuticals$4,633
By type
Compensation for services other than consulting (speaking, faculty)$45,880
Honoraria$2,998
Travel and Lodging$2,432
Consulting Fee$1,635
Food and Beverage$436

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Dec 23, 2025Alexion Pharmaceuticals, Inc.
Dec 23, 2025
Compensation for services other than consulting (speaking, faculty)
KOSELUGO · Oncology
Company’s descriptionSpeaker Fee
$4,960
Jun 19, 2025Alexion Pharmaceuticals, Inc.
Jun 19, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$4,960
May 8, 2025Alexion Pharmaceuticals, Inc.
May 8, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$4,960
May 8, 2025Alexion Pharmaceuticals, Inc.
May 8, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$4,960
Dec 18, 2025Alexion Pharmaceuticals, Inc.
Dec 18, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$4,960
Apr 3, 2025Alexion Pharmaceuticals, Inc.
Apr 3, 2025
Compensation for services other than consulting (speaking, faculty)
KOSELUGO · Oncology
Company’s descriptionSpeaker Fee
$3,720
Jul 31, 2025Alexion Pharmaceuticals, Inc.
Jul 31, 2025
Compensation for services other than consulting (speaking, faculty)
KOSELUGO · Oncology
Company’s descriptionSpeaker Fee
$3,100
Oct 8, 2025Day One Biopharmaceuticals
Oct 8, 2025
Honoraria
OJEMDA · ONCOLOGY
$2,998
Dec 11, 2025Alexion Pharmaceuticals, Inc.
Dec 11, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$1,860
Oct 30, 2025Alexion Pharmaceuticals, Inc.
Oct 30, 2025
Compensation for services other than consulting (speaking, faculty)
KOSELUGO · Oncology
Company’s descriptionSpeaker Fee
$1,860
All 28 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 23, 2025Alexion Pharmaceuticals, Inc.
Dec 23, 2025
Compensation for services other than consulting (speaking, faculty)
KOSELUGO · Oncology
Company’s descriptionSpeaker Fee
$4,960
Dec 18, 2025Alexion Pharmaceuticals, Inc.
Dec 18, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$4,960
Dec 18, 2025Day One Biopharmaceuticals
Dec 18, 2025
Consulting Fee
OJEMDA · ONCOLOGY
$1,635
Dec 11, 2025Alexion Pharmaceuticals, Inc.
Dec 11, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$1,860
Dec 10, 2025Alexion Pharmaceuticals, Inc.
Dec 10, 2025
Travel and Lodging
travel to Boston, MA
$301
Dec 10, 2025Alexion Pharmaceuticals, Inc.
Dec 10, 2025
Travel and Lodging
travel to Brookline, MA · in-kind
Company’s descriptionSpeaker Expenses
$196
Oct 30, 2025Alexion Pharmaceuticals, Inc.
Oct 30, 2025
Compensation for services other than consulting (speaking, faculty)
KOSELUGO · Oncology
Company’s descriptionSpeaker Fee
$1,860
Oct 30, 2025Alexion Pharmaceuticals, Inc.
Oct 30, 2025
Compensation for services other than consulting (speaking, faculty)
KOSELUGO · Oncology
Company’s descriptionSpeaker Fee
$1,860
Oct 23, 2025Alexion Pharmaceuticals, Inc.
Oct 23, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$1,860
Oct 8, 2025Day One Biopharmaceuticals
Oct 8, 2025
Honoraria
OJEMDA · ONCOLOGY
$2,998
Sep 25, 2025Alexion Pharmaceuticals, Inc.
Sep 25, 2025
Compensation for services other than consulting (speaking, faculty)
KOSELUGO · Oncology
Company’s descriptionSpeaker Fee
$1,860
Jul 31, 2025Alexion Pharmaceuticals, Inc.
Jul 31, 2025
Compensation for services other than consulting (speaking, faculty)
KOSELUGO · Oncology
Company’s descriptionSpeaker Fee
$3,100
Jul 21, 2025Alexion Pharmaceuticals, Inc.
Jul 21, 2025
Travel and Lodging
KOSELUGO · Oncology · travel to Morristown, NJ
$39.20
Jun 19, 2025Alexion Pharmaceuticals, Inc.
Jun 19, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$4,960
Jun 4, 2025Alexion Pharmaceuticals, Inc.
Jun 4, 2025
Compensation for services other than consulting (speaking, faculty)
KOSELUGO · Oncology
Company’s descriptionSpeaker Fee
$1,860
Jun 4, 2025Alexion Pharmaceuticals, Inc.
Jun 4, 2025
Travel and Lodging
travel to Canadaigua, NY
$375
Jun 4, 2025Alexion Pharmaceuticals, Inc.
Jun 4, 2025
Travel and Lodging
travel to Canandaigua, NY · in-kind
Company’s descriptionSpeaker Expenses
$351
May 8, 2025Alexion Pharmaceuticals, Inc.
May 8, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$4,960
May 8, 2025Alexion Pharmaceuticals, Inc.
May 8, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$4,960
May 1, 2025Alexion Pharmaceuticals, Inc.
May 1, 2025
Compensation for services other than consulting (speaking, faculty)
KOSELUGO · Oncology
Company’s descriptionSpeaker Fee
$1,860
Apr 29, 2025Alexion Pharmaceuticals, Inc.
Apr 29, 2025
Travel and Lodging
travel to Plymouth, MA
$330
Apr 29, 2025Alexion Pharmaceuticals, Inc.
Apr 29, 2025
Travel and Lodging
travel to Plymouth, MA
$330
Apr 29, 2025Alexion Pharmaceuticals, Inc.
Apr 29, 2025
Travel and Lodging
travel to Plymouth, MA · in-kind
Company’s descriptionSpeaker Expenses
$200
Apr 29, 2025Alexion Pharmaceuticals, Inc.
Apr 29, 2025
Travel and Lodging
travel to Plymouth, MA · in-kind
Company’s descriptionSpeaker Expenses
$200
Apr 3, 2025Alexion Pharmaceuticals, Inc.
Apr 3, 2025
Compensation for services other than consulting (speaking, faculty)
KOSELUGO · Oncology
Company’s descriptionSpeaker Fee
$3,720
Mar 20, 2025Alexion Pharmaceuticals, Inc.
Mar 20, 2025
Travel and Lodging
KOSELUGO · Oncology · travel to Melville, NY
$72.80
Mar 20, 2025Alexion Pharmaceuticals, Inc.
Mar 20, 2025
Travel and Lodging
KOSELUGO · Oncology · travel to Melville, NY
$36.44
Feb 14, 2025Alexion Pharmaceuticals, Inc.
Feb 14, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$1,240

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Massachusetts →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $91,390 in research payments for these studies, mostly to the institutions running them.

  • A Phase 1 Trial of Optune NovoTTF-200A System with and without Concomitant Temozolomide and Bevacizumab in Pediatric Patients with High Grade Glioma
    Novocure Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Pediatric Hematology & Oncology clinicians in Boston

Sources

NPI registry (CMS NPPES, November 2026; record last updated June 14, 2014), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1396918876. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.